Martijn P. Lolkema

Heidelberg University

Papers

1

Total Citations

179

H-Index

1

About

Dr. Martijn P. Lolkema is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for esophageal cancer treatment, with a particular focus on improving patient outcomes through rigorous clinical trials. His most impactful contribution is the landmark ROBOT trial, a randomized controlled trial comparing robot-assisted minimally invasive thoraco-laparoscopic esophagectomy to open transthoracic esophagectomy for resectable esophageal cancer. This seminal work, cited 179 times, demonstrated the feasibility and safety of robotic surgery in this complex procedure, establishing a new paradigm for surgical approach. Dr. Lolkema's research has been instrumental in reducing perioperative morbidity while maintaining oncological efficacy, directly influencing surgical guidelines worldwide. His work bridges the gap between technological innovation and evidence-based practice, making him a pivotal figure in the evolution of esophageal cancer surgery. Through his dedication to high-quality comparative effectiveness research, he has provided surgeons and patients with critical data to inform treatment decisions, cementing his reputation as a transformative voice in thoracic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
179
Total Citations
179
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)
179 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Heidelberg University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago